PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Pharma Sinks To A New Low

Consumers think less of the pharma industry than ever before if a new poll is any indication. Pharma unseated the federal government to win the dubious honor of last...
Continue Reading →
News

Is a Soliris patent review that big a threat to Alexion? Analysts are split

Things haven’t gone Alexion’s way lately: After investors cheered the possibility of an Amgen merger, the hoped-for partner advanced its Soliris patent challenge. Th...
Continue Reading →
News

South Korean CDMO consolidates, plants flag in California

by Eric Palmer South Korean conglomerate SK Holdings jumped decidedly into contract manufacturing a couple of years ago with deals for API plants in Ireland and t...
Continue Reading →
News

ESC: AstraZeneca’s SGLT2 med Farxiga flips script on competitors with 26% CV risk cut

by Kyle Blankenship AstraZeneca’s diabetes med Farxiga is still looking for the cardiovascular label updates its SGLT2 competitors already bear. But as of th...
Continue Reading →
News

New Sanofi CEO Paul Hudson embarks on fact-finding journey. What’s his next move?

by Eric Sagonowsky Sanofi's new CEO is on the job. Paul Hudson took the French drugmaker's helm from Olivier Brandicourt Monday, and he's setting out on a ...
Continue Reading →
News

Mylan’s Lantus copy derailed in the U.S. again by manufacturing ills

by Eric Palmer When Biocon’s insulin operations in Malaysia won EU approval two weeks ago, it sounded like the company had turned a quality corner. But that turn ...
Continue Reading →
News

MedCo’s PCSK9 challenger steals the show at ESC with winning data

by Angus Liu Whatever worries lingered around The Medicines Company’s longer-lasting PCSK9 cholesterol fighter should be largely cleared up now, thanks to a set o...
Continue Reading →
News

Greater Manchester NHS declares climate emergency

by Anna Smith NHS organisations in Greater Manchester have declared a climate emergency, committing to far-ranging action to "slash carbon emissions and avert pr...
Continue Reading →
News

Relief for Sun Pharma as regulator’s probe unearths no evidence of fraud: report

A preliminary investigation by the Securities and Exchange Board of India has cleared Sun Pharma of allegations of violation of securities laws. (Sun Pharma) Sun...
Continue Reading →
News

As API production consolidates abroad, U.S. regulators face safety concerns at home

Almost half of all FDA warnings letters since early 2018 were sent to Indian and Chinese plants, according to a report. (FDA) China and India, which are the larg...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026